Medication adherence, explained: what counts as "good" and why 80% is the line

If you take a chronic medication — anything you're meant to take every day, for months or years — your adherence percentage is the single number your prescriber most wants to know. It's also the number patients almost never bring to an appointment. This is a guide to what it means, what counts as "good enough," and why a small tracker beats a perfect memory.

The number you've never heard of: PDC and MPR

"Adherence" in the clinical literature is usually measured two ways:

• Proportion of Days Covered (PDC). Of the days in a given window (commonly 90, 180, or 365 days), how many were you actually covered by the medication — i.e. you had a dose for that day? PDC is the metric Medicare uses for its Star Ratings, the metric most pharmacy benefit managers track, and the metric most insurers use for "high-adherence" programs.
• Medication Possession Ratio (MPR). The total days of medication you have in hand divided by the days you were supposed to be on it. Subtly different from PDC, slightly more forgiving of overlap.

Both are expressed as a percentage. Both have 0.80 (80%) as the threshold for being labelled "adherent" in the literature and in clinical-practice systems. The 80% cutoff isn't arbitrary — it's an empirical threshold above which the medication's expected clinical benefit holds, and below which the benefit drops sharply for most chronic-disease drug classes.

How bad is the average?

The World Health Organization's 2003 report on adherence — still the most-cited reference in the field — put it bluntly:

"In developed countries, adherence to therapies for chronic diseases averages 50%. In developing countries, the rates are even lower."

That's not a typo. About half of people on long-term medication aren't taking it as prescribed. Brown and Bussell's 2011 Mayo Clinic Proceedings review reached the same number — roughly 50% adherence across chronic-medication categories — and added a cost estimate: around $100–290 billion per year in avoidable US healthcare costs, and about 125,000 deaths per year in the US attributable to non-adherence.

Put a different way: missing doses kills more Americans per year than breast cancer, more than fatal car crashes, more than firearm homicides. It just kills them slowly, one missed pill at a time, so it doesn't make the news.

Why people miss doses (the honest list)

Adherence research is full of taxonomies. The simple version — what real patients tell us when there's no clipboard in the room:

1. Forgetting. Especially in polypharmacy (four or more daily medications), where the mental load compounds. This is the largest single cause across studies and the easiest one to fix.
2. "I felt fine, so I stopped." Especially with antihypertensives, statins, and antidepressants — drugs whose benefit isn't a sensation. The lack of feedback feels like the drug "isn't doing anything."
3. Side effects. Real, often under-reported to the prescriber. Many side effects fade in 2–4 weeks; many don't. The right answer is a call to your prescriber, not silent discontinuation.
4. Cost. Especially in the US. Splitting pills, skipping doses, or extending the gap between refills is common when copays bite. Generics, manufacturer coupons, and 90-day mail-order fills often help — ask.
5. Complexity. "Twice a day with food, except on the days you take the other one." Schedules that require a chart are schedules that get missed. Talk to your pharmacist about consolidating times.
6. Confusion after a change. The week after a dose change, a switch from brand to generic, or a new prescription — error rates spike. This is the highest-risk moment, especially in elderly patients.

What "good adherence" looks like by medication class

The 80% threshold is the conventional cutoff for being classified as "adherent" in pharmacy databases and clinical decision-support systems. But the actual clinical impact of being slightly under varies by drug class. Some examples from the literature:

• Antihypertensives (blood pressure). Each 25-percentage-point drop in adherence is associated with measurably higher cardiovascular event rates. (Ho et al., Circulation, 2009.)
• Statins (cholesterol). Patients with PDC ≥ 80% have roughly 26% lower coronary-event risk than those below 40%. (Bansilal et al., J Am Heart Assoc, 2016.)
• Oral antidiabetics. Each 10% increase in adherence is associated with a ~0.1% drop in HbA1c — small per increment, large at the population level.
• HIV antiretrovirals. Historically, ≥95% was the threshold for viral suppression on older regimens. Modern integrase-inhibitor regimens are more forgiving, but adherence is still the single largest determinant of outcome.
• Antibiotics. A different game — the goal is finishing the course, not maintaining a long-term average. Stopping when symptoms resolve is the most common cause of recurrence and one of the documented contributors to antimicrobial resistance.

The pattern: for chronic medications, more is more, with diminishing returns above ~90%. For acute course medications (antibiotics, steroid tapers), completing the prescribed course matters more than the daily percentage.

What works (the evidence-based interventions)

The Cochrane review on adherence interventions looked across hundreds of trials. The honest answer: nothing is a silver bullet, but the cheapest interventions are the most cost-effective by a wide margin.

1. Visible cues in your environment. A pill organiser on the kitchen counter, a phone alarm, a checklist on the fridge, a tracker tab open on your laptop. Moving the cue from your memory to your environment is the largest single behavioural lever.
2. Habit stacking. Anchor the dose to an existing routine. "After my morning coffee, I take my pills" works because the coffee is the reliable cue. ("When I remember" is not a cue.)
3. Simplifying the regimen. Combining pills, switching to once-daily formulations, or moving all doses to the same time of day. Talk to your pharmacist — they're often the best person to suggest this.
4. Tracking and reviewing. Just writing down whether you took it is associated with higher adherence in nearly every study that looks at it. The mechanism is partly the cue, partly the small loss-aversion of breaking a streak, partly the honest feedback when you review the week.
5. Caregiver involvement. A partner, adult child, or roommate who can see whether the dose was taken is a strong adherence boost, especially in elderly or cognitively-impaired patients.

What the literature found doesn't work as well as you'd think: aggressive education programs, complex behavioural-therapy interventions, financial incentives (helpful but often not sustained). The simple, boring stuff outperforms the elaborate stuff.

How to bring your adherence number to an appointment

The number itself is more useful than any verbal description. "I take it most days" is unfalsifiable. "84% in the last 30 days, with two missed doses on the weekend trip" is actionable — your prescriber can immediately tell you whether 84% is fine for your specific medication or whether it's worth adjusting the schedule.

What we'd suggest bringing:

• The current medication list, with doses and frequencies as you actually take them (not just as they're written on the bottle).
• Your 30-day adherence percentage per medicine.
• The day-of-week pattern of misses — are weekends worse than weekdays? Mornings worse than evenings? That pattern tells the prescriber more about how to fix it than the percentage alone.
• Any side effects, even mild ones. "I feel a bit foggy in the morning since the dose change" is the kind of detail that gets buried otherwise.

The Medication Tracker exports exactly this in one click — a one-page printable summary you can hand to your prescriber or your pharmacist. Doctors and pharmacists strongly prefer this over a verbal recap; it makes the appointment shorter, more accurate, and meaningfully more useful.

One last thing: don't lie to the tracker

The single failure mode of any self-tracked adherence number is the temptation to mark a dose taken when you forgot, so the percentage looks better. Don't. The tracker is for you; the percentage is honest information about a real behaviour. Inflating it just gives you and your prescriber a false picture, which is worse than no picture. Miss a dose, mark it missed, look at the pattern, and adjust the cue. That's the whole game.

Start tracking — free, no signup →

This article is general health education, not medical advice. Adherence targets, drug-specific tolerances, and any change to your regimen must come from your prescriber and your pharmacist, not from a blog post.

← Back to all posts